Logo-ps
Pharm Sci. 2021;27(1): 14-31.
doi: 10.34172/PS.2020.25
  Abstract View: 278
  PDF Download: 130

Review

Boswellic Acids as Promising Leads in Drug Development against Alzheimer’s Disease

Hossein Haghaei 1 ORCID logo, Somaieh Soltani 2 ORCID logo, Seyedrafie Aref Hosseini 1* ORCID logo, Mohammad Reza Rashidi 2,3* ORCID logo, Saeed Karima 4 ORCID logo

1 Nutrition and food Sciences Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Drug Applied Research Center and Pharmacy Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Research Center for Pharmaceutical Nanotechnology and Pharmacy Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
4 Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.

Abstract

Biological activity of Boswellia extract (BE) has been attributed to its main active ingredients; i.e. Boswellic acids (BAs). BE/BAs possess a promising therapeutic potential in neurodegenerative disorders; including Alzheimer's disease (AD). The multifactorial nature of AD pathophysiology necessitates the development of the disease-modifying agents (DMA). Recent multi-targeting approaches for the DMAs development have brought more attention to the plant-derived compounds regarding their better human compatibility because of their biologic origin. This review addresses the current knowledge on the anti-AD activity of BE/BAs based on the available in silico, in vitro, in vivo studies and clinical trials. The contribution of BE/BAs in inflammatory pathways, Tau and β-amyloid proteins, microtubule functions, oxidative stress, cholinesterase and diabetes/insulin pathways involved in AD have been discussed. BAs efficacy in different AD-related pathways has been confirmed in vitro and in vivo. They can be considered as valuable scaffold/lead compounds for multi-targeted DMAs in anti-AD drug discovery and development.
Keywords: Alzheimer’s disease, Boswellic acids, Disease-modifying therapeutics, Multi-target drug, Plant derived scaffolds
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 279

Your browser does not support the canvas element.


PDF Download: 130

Your browser does not support the canvas element.

Submitted: 09 Jan 2020
Revision: 11 Mar 2020
Accepted: 11 Mar 2020
ePublished: 18 Mar 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)